Jiang G, Zhao M, Xia D. Refining the prognostic utility of CA19-9 in neoadjuvant therapy for pancreatic cancer: Emphasizing serial monitoring and subgroup differentiation. Pancreatology 2025 Sep 13:S1424-3903(25)00620-9. doi: 10.1016/j.pan.2025.
PMID: 40967962